CompletedNCT00999895
A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients
Observational studyAges 18–65GreeceSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Pátrai and 42 more locationsSee all locations and recruitment
Study information
Study start dateOctober 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 574
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Greece
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00999895
- Official title
Show the full official title
A Non-interventional, Prospective, Open-label Study for the Evaluation of the Selection and Outcome of the Antipsychotic Treatment Switch in Outpatients With Schizophrenia - ETOS Study
Recruitment & locations
CompletedPátrai · Nafplion · Tripoli
39 more locations
- Athens
- Dafni
- Drapetsona
- Exarcheia
- Glifada
- Ilioúpoli
- Ilissia
- Koridalos
- Marousi
- N. Makri
- P. Faliro
- Pangrati
- Peristeri
- Petroúpolis
- Piraeus
- Zografos
- Koropí
- Néo Irákleio
- Chania
- Kos
- Corfu
- Agrinio
- Alexandroupoli
- Lamia
- Heraklio
- Véroia
- Ioannina
- Karditsa
- Kavala
- Larissa
- Volos
- Kalamata
- Giannitsá
- Rethymno
- Komotini
- Serres
- Thessaloniki
- Trikala
- Thebes
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me